Prostate Cancer
Survey on prostate MRI reading and interpretation among urology residents in Italy, Brazil and the UK: a cry for help.
October 27, 2022
First communication on the efficacy of combined 177Lutetium-PSMA with immunotherapy outside prostate cancer.
October 27, 2022
Prostate cancer-related anxiety among long-term survivors after radical prostatectomy: A longitudinal study.
October 27, 2022
Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial.
October 26, 2022
Role of MRI, Ultrasound, and Computed Tomography in the Management of Prostate Cancer.
October 26, 2022
Selecting interventions for a psychosocial support program for prostate cancer patients undergoing active surveillance: A modified Delphi study.
October 26, 2022
Feasibility of Global Assessment of Bone Metastases in Prostate Cancer with 18F-Sodium Fluoride-PET/Computed Tomography.
October 25, 2022
Prevalence of multimorbidity in men of African descent with and without prostate cancer in Soweto, South Africa.
October 25, 2022
Phase II trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody Armed Activated T Cells in Metastatic Castrate Resistant Prostate Cancer.
October 25, 2022
The Association between Financial Toxicity and Treatment Regret in Men with Localized Prostate Cancer.
October 25, 2022
Prostate Cancer Imaging with 18F-Fluciclovine.
October 24, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.
October 24, 2022